Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PHENPROCOUMON
- Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
- Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
- Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
- Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation
- Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
- Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)
- Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon
- Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
- Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)
- Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
- Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
- Triple vs. Dual Therapy
- Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
- A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy
- Antithrombotic Triple Therapy in Humans
- Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
- Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
- Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
- Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
- D-Dimer Guided Oral Anticoagulant Treatment (OAT)
- Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon
- Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications
Clinical trials list
click for details